In lung cancer, MED19 could promote tumor proliferation, tumorigenesis, metastasis, and enhance chemo-sensitivity to cisplatin in non-small cell lung cancer cells [14–16]. This evidence concerns the gene MED19 and non-small cell lung carcinoma.